Classroom Access
click here
0Item(s)
0 Items View Cart

You have no items in your shopping cart.

Product was successfully added to your shopping cart.
  • Understanding Antihyperlipidemic Drugs Understanding Antihyperlipidemic Drugs
Previous

Treating Asthma: A Pharmacological Approach

Previous

Understanding Fluids and Electrolytes Balance

Understanding Antihyperlipidemic Drugs

2 CE Credit Hours

Quick Overview

Managing dyslipidemia is a cornerstone of cardiovascular disease prevention, and nurses play a critical role in educating patients and supporting medication adherence. Understanding Antihyperlipidemic Drugs offers a comprehensive and up-to-date overview of the pharmacologic agents used to manage elevated lipid levels, including statins, fibrates, bile acid sequestrants, PCSK9 inhibitors, and more. This course empowers healthcare professionals with the knowledge to recognize drug mechanisms, side effects, contraindications, and monitoring parameters enhancing patient safety and therapeutic outcomes. Enroll now to build your expertise and confidently support evidence-based lipid management in your clinical practice.

Details

Dyslipidemia is a major modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD), making the pharmacologic management of abnormal lipid profiles a critical component of preventive care. Understanding Antihyperlipidemic Drugs provides a detailed review of lipid-lowering agents, their mechanisms of action, clinical indications, safety profiles, and nursing considerations.

This course is designed to equip nurses with a comprehensive understanding of how antihyperlipidemic medications—such as statins, fibrates, niacin, cholesterol absorption inhibitors, and PCSK9 inhibitors—work to reduce LDL-C, raise HDL-C, and manage triglycerides. Emphasis is placed on individualized patient care, medication monitoring, and managing adverse effects to optimize adherence and outcomes.

Topics covered include:

  • Lipid Physiology and Classification: Understanding the roles of LDL, HDL, VLDL, and triglycerides in cardiovascular health.
  • Statins (HMG-CoA Reductase Inhibitors): First-line agents for LDL-C reduction; evidence for primary and secondary ASCVD prevention; monitoring and side effect management.
  • Fibrates and Omega-3 Fatty Acids: Agents for hypertriglyceridemia; risks and benefits in pancreatitis prevention and cardiovascular risk reduction.
  • Niacin and Bile Acid Sequestrants: Mechanisms, therapeutic roles, and clinical limitations.
  • Cholesterol Absorption Inhibitors (e.g., ezetimibe): Combination therapy approaches and LDL-lowering synergy with statins.
  • PCSK9 Inhibitors: Monoclonal antibodies targeting LDL-receptor degradation; indications for familial hypercholesterolemia and statin-intolerant patients.
  • Emerging Therapies: Overview of inclisiran and bempedoic acid and their potential role in lipid management.
  • Nursing Implications: Patient education, adherence strategies, lifestyle counseling, and follow-up laboratory monitoring.
  • Drug-Drug Interactions and Contraindications: Special considerations in polypharmacy, liver dysfunction, and pregnancy.
  • Case-Based Applications: Real-world scenarios to support clinical reasoning and treatment personalization.

Completion Requirements:

To receive full CE credit, participants must:

  • Register for the course.
  • Complete all course modules and assigned readings.
  • Pass the post-test with a score of 70% or higher.
  • Submit course evaluations for each module.

Course materials may include case scenarios, state-specific policy references, and downloadable clinical tools for use in practice.


Important Disclosures:

  • Conflict of Interest: Faculty and planners report no relevant financial relationships.
  • Commercial Support: This activity received no external commercial funding or sponsorship.
  • Non-Endorsement: Accreditation does not imply endorsement of any commercial products or companies.
  • Off-Label Product Use: Any mention of off-label drug use is consistent with current clinical guidelines and evidence-based practice.
A provider discusses lipid panel results with a patient to select a therapy, a key skill from the Antihyperlipidemic Drugs CE Nursing course.

Key Course Benefits:

CEBroker 24hr Bagde
  • CE Credit Hours: 2 CE Contact Hours
  • Pharmacology-Focused: Enhances nursing knowledge in medication management for lipid disorders.
  • Clinical Relevance: Supports safe, evidence-based use of lipid-lowering drugs in diverse patient populations.
  • Decision-Making Confidence: Equips clinicians with up-to-date guidance to support provider collaboration and patient education

Approvals and Accreditation:

The National Healthcare Institute (NHI) is approved as a continuing education provider by:

Florida Board of Nursing

Registered Nurse, Clinical Nurse Specialist, Advanced Registered Nurse Practitioner

District of Columbia Board of Nursing

Registered Nurse, Nurse Anesthetist, Clinical Nurse Specialist, Midwife, Advanced Practice Nurse

Georgia Board of Nursing

Registered Nurse

All NHI courses adhere to the rigorous standards of the American Nurses Credentialing Center’s Commission on Accreditation, ensuring accuracy, integrity, and professional value in continuing education.